🔎 Trials Near Me

Home › Thoracoabdominal Aortic Aneurysm › NCT00483249

Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria

1. Aortic aneurysms:

   * greater than or equal to 6 cm in diameter in men,
   * greater than or equal to 5.5 cm in diameter in women,
   * and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,
   * and/or iliac aneurysms larger than 4 cm in diameter.
2. Anticipated mortality comparable to published rates with conventional surgical treatment.
3. Life expectancy more than 2 years.
4. Ability to give informed consent.
5. Willingness to comply with follow-up schedule.
6. Suitable arterial anatomy for endovascular repair.

Exclusion Criteria

1. Free rupture of the aneurysm.
2. Pregnancy.
3. Known allergy to Nitinol, stainless steel, or polyester.
4. Unwillingness or inability to comply with the follow up schedule.
5. Serious systemic or groin infection.
6. Uncorrectable coagulopathy.

About the study

This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

What is being tested

Sponsor: Warren J. Gasper, MD · Participants: 250 · Started: 2005-05

Contact the study team

Official record on ClinicalTrials.gov — NCT00483249

Locations in the U.S.

CaliforniaDivision of Vascular Surgery, SFVAMC, San Francisco
Division of Vascular Surgery, UCSF, San Francisco

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.